These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 10411412)

  • 1. An open study of tinea capitis in 50 children treated with a 2-week course of oral terbinafine.
    Krafchik B; Pelletier J
    J Am Acad Dermatol; 1999 Jul; 41(1):60-3. PubMed ID: 10411412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
    Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF
    J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of efficacy of 6-week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children.
    Dragos V; Lunder M
    Pediatr Dermatol; 1997; 14(1):46-8. PubMed ID: 9050765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
    Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
    Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
    Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
    Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An experience from an outbreak of tinea capitis gladiatorum due to Trichophyton tonsurans.
    Ergin S; Ergin C; Erdoğan BS; Kaleli I; Evliyaoğlu D
    Clin Exp Dermatol; 2006 Mar; 31(2):212-4. PubMed ID: 16487093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.
    Cáceres-Ríos H; Rueda M; Ballona R; Bustamante B
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):80-4. PubMed ID: 10607324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis.
    Haroon TS; Hussain I; Aman S; Jahangir M; Kazmi AH; Sami AR; Nagi AH; Alvi KH; Iqbal N; Khan KA; Aziz R
    Br J Dermatol; 1996 Jul; 135(1):86-8. PubMed ID: 8776365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Griseofulvin and terbinafine in the treatment of tinea capitis in children.
    Rademaker M; Havill S
    N Z Med J; 1998 Feb; 111(1060):55-7. PubMed ID: 9539918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terbinafine pulse therapy is effective in tinea capitis.
    Gupta AK; Adam P
    Pediatr Dermatol; 1998; 15(1):56-8. PubMed ID: 9496808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
    Deng S; Hu H; Abliz P; Wan Z; Wang A; Cheng W; Li R
    Mycopathologia; 2011 Nov; 172(5):365-72. PubMed ID: 21701791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trichophyton tonsurans tinea capitis and tinea corporis: treatment and follow-up of four affected family members.
    Ravenscroft J; Goodfield MJ; Evans EG
    Pediatr Dermatol; 2000; 17(5):407-9. PubMed ID: 11085674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of oral terbinafine (Lamisil) in children.
    Krafchik B; Pelletier J
    Dermatology; 1997; 194 Suppl 1():43-4. PubMed ID: 9154402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study.
    Friedlander SF; Aly R; Krafchik B; Blumer J; Honig P; Stewart D; Lucky AW; Gupta AK; Babel DE; Abrams B; Gourmala N; Wraith L; Paul C;
    Pediatrics; 2002 Apr; 109(4):602-7. PubMed ID: 11927703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US.
    Van Duyn Graham L; Elewski BE
    Mycoses; 2011 Nov; 54(6):e679-85. PubMed ID: 21668517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes for tinea capitis in a skin of color population.
    Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB
    J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatments for tinea capitis.
    Chan YC; Friedlander SF
    Curr Opin Infect Dis; 2004 Apr; 17(2):97-103. PubMed ID: 15021047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of 8 weeks' treatment with terbinafine in children with tinea capitis caused by Microsporum canis: a comparison of three doses.
    Devliotou-Panagiotidou D; Koussidou-Eremondi TH
    J Eur Acad Dermatol Venereol; 2004 Mar; 18(2):155-9. PubMed ID: 15009293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral terbinafine in tinea capitis in children.
    Gruseck E; Splanemann V; Bleck O; Ring J; Abeck D
    Mycoses; 1996; 39(5-6):237-40. PubMed ID: 8909037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.